Literature DB >> 24231914

[Clarithromycin for monotherapy of B-cell MALT lymphoma?].

C Auw-Hädrich, J Finke, A Serr, H Mittelviefhaus, C Bogdan, T Reinhard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24231914     DOI： 10.1007/s00347-013-2974-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  8 in total

1.  Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial.

Authors:  Silvia Govi; Giuseppina P Dognini; Giada Licata; Roberto Crocchiolo; Antonio Giordano Resti; Maurilio Ponzoni; Andrés J M Ferreri
Journal:  Br J Haematol       Date:  2010-04-28       Impact factor: 6.998

Review 2.  Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed.

Authors:  C Thieblemont; F Berger; C Dumontet; I Moullet; F Bouafia; P Felman; G Salles; B Coiffier
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

3.  Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial.

Authors:  Andrés J M Ferreri; Silvia Govi; Elisa Pasini; Silvia Mappa; Francesco Bertoni; Francesco Zaja; Carlos Montalbán; Caterina Stelitano; Maria Elena Cabrera; Antonio Giordano Resti; Letterio Salvatore Politi; Claudio Doglioni; Franco Cavalli; Emanuele Zucca; Maurilio Ponzoni; Riccardo Dolcetti
Journal:  J Clin Oncol       Date:  2012-07-16       Impact factor: 44.544

4.  High relapse rate in patients with MALT lymphoma warrants lifelong follow-up.

Authors:  Markus Raderer; Berthold Streubel; Stefan Woehrer; Andreas Puespoek; Ulrich Jaeger; Michael Formanek; Andreas Chott
Journal:  Clin Cancer Res       Date:  2005-05-01       Impact factor: 12.531

5.  Two cases with pulmonary mucosa-associated lymphoid tissue lymphoma successfully treated with clarithromycin.

Authors:  Yuji Ishimatsu; Hiroshi Mukae; Kiyoshi Matsumoto; Tatsuhiko Harada; Atsuko Hara; Shintaro Hara; Misato Amenomori; Hanako Fujita; Noriho Sakamoto; Tomayoshi Hayashi; Shigeru Kohno
Journal:  Chest       Date:  2010-09       Impact factor: 9.410

6.  Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma.

Authors:  K Tanimoto; A Kaneko; S Suzuki; N Sekiguchi; D Maruyama; S W Kim; T Watanabe; Y Kobayashi; Y Kagami; A Maeshima; Y Matsuno; K Tobinai
Journal:  Ann Oncol       Date:  2005-10-19       Impact factor: 32.976

7.  [Clarithromycin therapy of a B cell MALT lymphoma].

Authors:  L Danilko; K Haas; U Schönherr; G Tschurtschenthaler
Journal:  Ophthalmologe       Date:  2013-05       Impact factor: 1.059

Review 8.  Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literature.

Authors:  Barbara Kiesewetter; Markus Raderer
Journal:  Blood       Date:  2013-06-14       Impact factor: 22.113
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.